Lantern Pharma (LTRN) announced the establishment of an AI center of excellence and advanced agentic labs in Bengaluru, India. The initiative is designed to industrialize its AI-driven drug discovery capabilities at a global scale. The center will focus on data engineering, refining ML-ready disease models, and integrating with global biopharma customers. Lantern stated the expansion is expected to be cash flow neutral.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LTRN: